Nano-X Imaging Secures $15 Million in Direct Offering to Advance Accessible Medical Imaging Technology

Nano-X Imaging Ltd. (NASDAQ: NNOX) has entered into a securities purchase agreement with a single institutional investor for a registered direct offering expected to generate approximately $15 million in gross proceeds. The company will sell 3,826,530 ordinary shares in this financing arrangement, with Titan Partners Group, a division of American Capital Partners, serving as sole placement agent. The transaction is scheduled to close on or about November 25, 2025, with net proceeds designated for working capital and general corporate purposes.

The funding comes at a critical time for Nano-X as the company continues its mission to transform global healthcare through accessible medical imaging technology. The company's comprehensive ecosystem includes multiple interconnected technologies designed to improve early disease detection and treatment outcomes. This financial injection will support the expansion of Nanox's vision to bring affordable medical imaging to broader populations, potentially addressing healthcare disparities in underserved communities.

At the core of Nano-X's technology platform is the Nanox.ARC, a multi-source digital tomosynthesis system designed to be both cost-effective and user-friendly. This system represents a significant departure from traditional medical imaging equipment, which often carries prohibitive costs that limit accessibility in many healthcare settings. The company's approach could potentially democratize medical imaging by making advanced diagnostic tools available in primary care offices and community health centers rather than being confined to major medical facilities.

The company's artificial intelligence capabilities, developed through Nanox.AI LTD, provide a suite of algorithms that augment the reading of routine CT imaging to highlight early signs often associated with chronic diseases. This technology aims to improve diagnostic accuracy and efficiency, potentially leading to earlier interventions and better patient outcomes. The integration of AI represents a growing trend in medical technology where machine learning enhances human diagnostic capabilities.

Nanox.CLOUD serves as the backbone of the company's technological infrastructure, providing a cloud-based software platform that manages and stores data collected by Nanox devices while offering users tools for in-depth imaging analysis. This cloud component enables remote access to medical imaging data, facilitating telemedicine and remote consultations. The platform's capabilities align with the increasing shift toward digital health solutions and remote patient monitoring.

Through its subsidiary, USARAD Holdings Inc., Nano-X operates Nanox.MARKETPLACE, a proprietary decentralized marketplace that provides remote access to radiology and cardiology experts along with a comprehensive teleradiology services platform. This marketplace concept addresses the global shortage of specialized medical professionals by connecting healthcare providers with expert diagnosticians regardless of geographical location. More information about Nano-X's comprehensive vision can be found at https://www.nanox.vision/.

The $15 million financing represents a significant vote of confidence in Nano-X's business model and technological approach at a time when healthcare systems worldwide are seeking more efficient and accessible diagnostic solutions. As healthcare continues to evolve toward preventive models and value-based care, technologies that enable early detection and intervention become increasingly valuable. The successful completion of this offering could accelerate the deployment of Nano-X's technology platform and expand its market reach, potentially impacting how medical imaging is delivered and accessed globally.